Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 820 results for "ema"

EU proposes new rules for first-in-human trials
Business Line

EMA proposes changes to current guidance on first-in-human tri...

The European Medicines Agency (EMA), in cooperation with the European Commission and the Member States of the European Union (EU), is proposing changes to current guidance on first-in-human clinical trials to further improve strategies to identify ... PharmaBiz, 1 day ago
[x]  

800 images for ema

Splash 247, 2 days ago
Shipping Herald, 2 days ago
Business Standard India, 2 days ago
Chornicle.lu, 3 days ago
RIPR.org, 2 days ago
Pharmafile, 1 day ago
Enterprise Management Associates, 1 day ago
American Banking News - Forex, 1 day ago
BioPharma-Reporter.com, 4 days ago
Financial Express, 2 days ago
BioPharma-Reporter.com

EMA Accepts Pegfilgastim Biosimilar for Review

Mylan and Biocon announced that the European Medicines Agency (EMA) has accepted for review Mylan's Marketing Authorization Application (MAA) for its proposed biosimilar to pegfilgrastim. The drug was co-developed by Biocon and Mylan and is used to ...
 PharmTech.com1 day ago BRIEF-Merck says EMA has accepted file for formulation of Isentress for review  Reuters UK2 days ago EMA agrees to review Biocon and Mylan's Marketing Authorization Application for biosimilar Pegfilgrastim  PharmaBiz2 days ago EMA accepts to review Mylan and Biocon's regulatory submission for Pegfilgrastim  Express Pharma2 days ago
[x]  
Libya News Today

EU watchdog flags faulty generic drug data, backs sales halt

July 22 (Reuters) - The European Medicines Agency (EMA) recommended suspending sales of some generic drugs after a review found that data collected by a contract research company in India for their approval was unreliable. The EMA's list included ...
 Yahoo! Finance1 day ago
[x]  
Reuters

Flawed Indian studies spur EU regulator to back drug suspensions

EU drug regulator EMA recommends suspension of a number of medicines that were tested in India, after an inspection of the site found substitution and manipulation of the study samples London: The European Medicines Agency recommended suspending a ...
 Livemint.com1 day ago Brexit spells upheaval for EU and UK drug regulation  Reuters4 weeks ago Brexit will disrupt EU and UK drug regulation  Asian Age3 weeks ago

Precious Metals Preview: Massive Losses For Gold, Silver Crashes Too

COMEX Gold futures tumbled sharply yesterday after breaking under their 20 day Exponential Moving Average (EMA). Earlier this week, Gold witnessed some steady buying support amid tentative moves in equities and bargain buying. However, weak Indian ...
 India Infoline3 days ago Gold Lingers Just Above 20 Day EMA, Equities Rise In Europe  India Infoline4 days ago

EMA committee classifies Advaxis Lm immunotherapy candidate, AXAL as advanced-therapy medicinal product

Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, announced that its lead Lm immunotherapy candidate, axalimogene filolisbac (AXAL), has been classified as an advanced-therapy medicinal product (ATMP) for the ...
 PharmaBiz4 days ago BRIEF-EMA classifies Advaxis cervical cancer drug as an advanced-therapy medicinal product  Reuters UK6 days ago

EMA India reports standalone net loss of Rs 2.35 crore in the June 2016 quarter

Sales rise 88.89% to Rs 0.34 crore
 Business Standard3 days ago EMA India reports standalone net profit of Rs 0.06 crore in the March 2016 quarter  Business Standard2 months ago
Business Standard India

Biocon up over 5% post Q1 results, EMA review of Biosimilar

Related to : Biocon Ltd Biocon Ltd BSE 22 Jul 16 | 10:23 AM 743.00 41.5 (5.92%) NSE 22 Jul 16 | 10:14 AM 745.85 45.25 (6.46%) Biocon has surged 7% to Rs 749 on the BSE after the company reported 35% year-on-year (YoY) jump in its ...
 Smart Investor2 days ago Biocon up over 5 percent post Q1 results, EMA review of biosimilar  FirstWord Pharma1 day ago Biocon hits new all-time high post Q1 results, shares surge over 15%  Financial Express2 days ago Strong biologics performance boosted Q1: Biocon CMD Kiran Shaw  Moneycontrol.com2 days ago
[x]  

EMA India to hold board meeting

On 20 July 2016
 Business Standard1 week ago EMA India's board meeting on July 20, 2016  Money Control1 week ago EMA India's board meeting on May 24, 2016  Money Control2 months ago

EMA Suspends Drugs Due to Flawed Bioequivalence Studies

The agency recommends suspending drugs developed with bioequivalence studies performed at Semler Research Centre Private Ltd, Bangalore, India. On July 22, 2016, the European Medicines Agency (EMA) recommended the suspension of approved ...
 PharmTech.com1 day ago News and press releases: EMA website briefly unavailable on 25 July  European Medicines Agency2 days ago EMA recommends suspension of medicines over flawed studies at Semler Research Centre  FirstWord Pharma2 days ago News and press releases: EMA recommends suspension of medicines over flawed studies at Semler Research Centre  European Medicines Agency1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ema
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less